Refine your search
-
Authors
-
Item types
-
Topics
- *Acute Coronary Syndrome
- *Anti-Inflammatory Agents/ad [Administration & Dosage]
- *Biological Products/ad [Administration & Dosage]
- *Cardiovascular Agents/ad [Administration & Dosage]
- *Cardiovascular Diseases/dt [Drug Therapy]
- *Cytokines/ai [Antagonists & Inhibitors]
- *Inflammation Mediators/ai [Antagonists & Inhibitors]
- *Proprotein Convertase 9
- Animals
- Anti-Inflammatory Agents/ae [Adverse Effects]
- Antibodies, Monoclonal, Humanized
- Biological Products/ae [Adverse Effects]
- Cardiotoxicity
- Cardiovascular Agents/ae [Adverse Effects]
- Cardiovascular Diseases/ge [Genetics]
- Cardiovascular Diseases/im [Immunology]
- Cardiovascular Diseases/me [Metabolism]
- Cost-Benefit Analysis
- Cytokines/im [Immunology]
- Humans
- Show more
- Show less
-
Collections
-
Languages